CA2514878C - Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees - Google Patents

Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees Download PDF

Info

Publication number
CA2514878C
CA2514878C CA2514878A CA2514878A CA2514878C CA 2514878 C CA2514878 C CA 2514878C CA 2514878 A CA2514878 A CA 2514878A CA 2514878 A CA2514878 A CA 2514878A CA 2514878 C CA2514878 C CA 2514878C
Authority
CA
Canada
Prior art keywords
dosage form
cyclodextrin
solubility
cyclodextrins
methylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2514878A
Other languages
English (en)
Other versions
CA2514878A1 (fr
Inventor
Rong-Kun Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Supernus Pharmaceuticals Inc
Original Assignee
Supernus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supernus Pharmaceuticals Inc filed Critical Supernus Pharmaceuticals Inc
Priority claimed from PCT/US2004/002920 external-priority patent/WO2004069187A2/fr
Publication of CA2514878A1 publication Critical patent/CA2514878A1/fr
Application granted granted Critical
Publication of CA2514878C publication Critical patent/CA2514878C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2514878A 2003-02-03 2004-02-02 Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees Expired - Fee Related CA2514878C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US44445503P 2003-02-03 2003-02-03
US44444503P 2003-02-03 2003-02-03
US60/444,455(CIP) 2003-02-03
US60/444,455 2003-02-03
PCT/US2004/002920 WO2004069187A2 (fr) 2003-02-03 2004-02-02 Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees

Publications (2)

Publication Number Publication Date
CA2514878A1 CA2514878A1 (fr) 2004-08-19
CA2514878C true CA2514878C (fr) 2011-04-05

Family

ID=35206799

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2514878A Expired - Fee Related CA2514878C (fr) 2003-02-03 2004-02-02 Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees

Country Status (1)

Country Link
CA (1) CA2514878C (fr)

Also Published As

Publication number Publication date
CA2514878A1 (fr) 2004-08-19

Similar Documents

Publication Publication Date Title
US7678776B2 (en) Inclusion complexes of butylphthalide with cyclodextrin or its derivatives, a process for their preparation and the use thereof
Duchěne et al. Pharmaceutical uses of cyclodextrins and derivatives
JP4439596B2 (ja) 長期の貯蔵寿命を有する、極性薬物又は極性プロドラッグを含有する医薬組成物、及びその製造方法
KR100708360B1 (ko) 라스-파르네실트란스퍼라제 억제제와술포부틸에테르-7-β-시클로덱스트린 또는2-히드록시프로필-β-시클로덱스트린과의 착물 및 방법
CA2414064C (fr) Composition anesthesique aqueuse claire
US10864183B2 (en) Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
KR20050013548A (ko) 유기 약제 및 베타-시클로덱스트린 유도체의 복합체 및 그제조 방법
EP2434886A1 (fr) Compositions injectables à base de melphalan comprenant un dérivé de cyclodextrine et leurs procédés de fabrication et d'utilisation
Szejtli Cyclodextrin complexed generic drugs are generally not bio-equivalent with the reference products: therefore the increase in number of marketed drug/cyclodextrin formulations is so slow
JPH0336827B2 (fr)
US7259153B2 (en) Drug formulation and delivery using crystalline methylated cyclodextrins
Agrawal et al. Cyclodextrins—a review on pharmaceutical application for drug delivery
Khan et al. Cyclodextrin: an overview
WO2002055076A1 (fr) Preparation pharmaceutique contenant de la cyclodextrine
JP2000086539A (ja) 包接複合体を製造するための塩の選別法
CA2514878C (fr) Formulation et administration d'un medicament a l'aide de cyclodextrines cristallines methylees
Kovvasu Cyclodextrins and their application in enhancing the solubility, dissolution rate and bioavailability
FI118537B (fi) Menetelmä syklodekstriinin kompleksoitumisen lisäämiseksi
WO1996041646A2 (fr) Compositions pharmaceutiques contenant du lornoxicam et de la cyclodextrine
JP2005521712A (ja) 弱塩基の可溶化
CN106727363B (zh) 核苷氨基磷酸酯类前药的冻干形式的药物组合物
Dumore et al. Cyclodextrins Inclusion Complexation: A Review
JPH01131202A (ja) 新規な腸溶性分子カプセル
US20040242538A1 (en) Method to improve complexation efficacy and produce high-energy cylodextrincomplexes
Stella SBE7-B-CD, A NEW, NOVEL AND SAFE POLYANIONIC ẞ-CYCLODEXTRIN DERIVATIVE: BIOMEDICAL APPLICATIONS.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20170202